TIANYUAN HEALTH issues profit warning, expects to incur a net loss of approximately HKD 8.4 million in the first half of the year
TIANYUAN HEALTH expects to record a net loss of approximately HKD 8.4 million in the first half of 2025, an improvement compared to the previous period's loss of HKD 9 million. Total revenue is expected to be around HKD 8.4 million, a year-on-year decrease of approximately 44%. The main reason is the suspension of operations and renovations at Shanghai Yuyue Weilai Medical Aesthetic Hospital, resulting in a decrease in medical business revenue of no less than HKD 6.2 million. The board believes that the net loss is primarily due to the decrease in total revenue
According to the Zhitong Finance APP, TIANYUAN HEALTH (00557) announced that it expects the group to achieve total revenue of approximately HKD 8.4 million in the first half of 2025, a year-on-year decrease of about 44%. The expected decrease in total revenue is mainly attributed to Shanghai Yuyue Weilai Medical Beauty Hospital Co., Ltd. (in which the group has partial equity and is a plastic surgery specialty hospital located in Shanghai, People's Republic of China) suspending business operations and renovations in the first half of 2025, resulting in a projected decrease in the group's medical business revenue of no less than approximately HKD 6.2 million to about HKD 500,000 (previous period: approximately HKD 6.7 million).
In addition, the group expects to incur a net loss of approximately HKD 8.4 million during the interim period (previous period: approximately HKD 9 million). Based on the relevant information currently available to the company, the board believes that the estimated net loss for the interim period is mainly due to the estimated decrease in total revenue compared to the previous period, offset by a corresponding reduction in operating costs
